BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

American CryoStem Corporation Awarded Patent for Cell Culture Media


9/1/2011 8:46:32 AM

RED BANK, NJ--(Marketwire - September 01, 2011) - American CryoStem Corporation (OTCBB: CRYO) announced the grant to it of a patent by the United States Patent Office (USPTO).

American CryoStem Corporation (the "Company") has been awarded U.S. Patent Number 7,989,205, entitled "Cell Culture Media, Kits, and Methods of Use" (the "Patent"), by the USPTO. This Patent covers a unique product for cellular growth in the processing of adult stem cells. This is significant to the Company for the advancement of its research, clinical and cosmetic applications. The Company's management believes that the Patent will support the Company's efforts in its goal to establish itself as a leader in the preparation of autologous stem cells for use in regenerative medicine. The Patent includes a specific human formulation to overcome the concerns and issues prevalent in the FDA's and other regulatory agencies' guidance when using non-human biologic materials in the preparation of stem cells for human use.

John S Arnone, CEO, stated, "We are pleased to have the Patent granted to the Company by the USPTO. We believe the Patent will be instrumental to the industry based on its cellular growth properties and absence of non-human biologic material. Further, as stem cell and regenerative medicine advances in the United States, as it has globally, the Company is confident the Patent, together with our core technology and our intellectual property regarding methods, formulations, devices and products will allow us to enter into additional partnerships and collaborations with other industry participants. The Patent validates our corporate direction and enhances our strategy to obtain strong intellectual property protection."

Anthony Dudzinski, COO, stated, "We believe the Patent on specie specific media gives the Company a unique market position by alleviating the significant regulatory requirements associated with products containing fetal bovine serum or other non-human biologic components. The Patent is important and will accelerate the development and commercialization of additional Company products and services. We are excited and very optimistic regarding our place in the stem cell industry and the value of our products and services."

About American CryoStem: The Company markets a core clinical processing platform for Adipose (fat) Derived Adult Stem Cells. The Company's services provide for the collection, processing, and cryopreservation (long term storage) of adult stem cells, allowing healthy individuals to privately preserve their stem cells for future use in personalized and regenerative medicine at an affordable price. Adult stem cell treatments are currently being utilized to potentially heal one's own body of diseases and chronic conditions. The Company's proprietary platform provides streamlined and affordable processing and cryopreservation of Adipose Derived Stem Cells and Adipose Tissue for autologous (self) use.


Contact:
American CryoStem Corporation
188 East Bergen Place, Suite 204
Red Bank, NJ 07701
732-747-1007



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES